Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- SPIRITIndependent statistical analysis of Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00244842).
- SPIRITIndependent statistical analysis of Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System: Complete Statistical AnalysisIndependent statistical analysis of SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study): Complete Statistical AnalysisIndependent statistical analysis of SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study): primary…
- SPIRITT – Second-Line Panitumumab Irinotecan Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418938).
- Spironolactone in Patients With Single Ventricle Heart: Complete Statistical AnalysisIndependent statistical analysis of Spironolactone in Patients With Single Ventricle Heart: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00211081).
- Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SpO2 System Accuracy Testing With Different Sensors: Complete Statistical AnalysisIndependent statistical analysis of SpO2 System Accuracy Testing With Different Sensors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01613222).
- SpO2 Validation of Noninvasive Red Diamond Disposable Pulse Oximeter Sensor: Complete Statistical AnalysisIndependent statistical analysis of SpO2 Validation of Noninvasive Red Diamond Disposable Pulse Oximeter Sensor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03124602).
- SPOTIndependent statistical analysis of UH3 Pragmatic Suicide Prevention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02326883).
- SpotlightIndependent statistical analysis of A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SPOTLIGHT203Independent statistical analysis of BO-112 With Pembrolizumab in Unresectable Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04570332).
- SPREADIndependent statistical analysis of Sleep to Prevent Evolving Affecting Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02988375).
- SPRINGIndependent statistical analysis of Survival Prolongation by Rationale Innovative Genomics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03386929).
- SPRING-2Independent statistical analysis of A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPTIndependent statistical analysis of Brain Biomarkers of Response to Treatment for Apraxia of Speech: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02046941).
- SPT for Sensitization of Collagen Dressing: Complete Statistical AnalysisIndependent statistical analysis of SPT for Sensitization of Collagen Dressing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06271993).
- Sputum-derived Cellular Targets After Xolair (Omalizumab): Complete Statistical AnalysisIndependent statistical analysis of Sputum-derived Cellular Targets After Xolair (Omalizumab): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02658877).
- SPYDSIndependent statistical analysis of Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02524418).
- SQ53 Disinfectant Wipes for Prevention of CRBSI: Complete Statistical AnalysisIndependent statistical analysis of SQ53 Disinfectant Wipes for Prevention of CRBSI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04822467).
- SRSIndependent statistical analysis of Stereotactic Radiosurgery (SRS) for Spine Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00593320).
- SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01362790).
- SSB 11-02Independent statistical analysis of Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1: primary endpoint results, effect estimate with confidence…
- SSETDIndependent statistical analysis of Supportive and Supportive-Expressive Treatment for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02728557).
- SSVSIndependent statistical analysis of Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- St. Joe’s Invitation Effectiveness Study: Complete Statistical AnalysisIndependent statistical analysis of St. Joe's Invitation Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04658888).
- Stability of the Medial Pivot Total Knee Prosthesis: Complete Statistical AnalysisIndependent statistical analysis of Stability of the Medial Pivot Total Knee Prosthesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02577978).
- Staccato Loxapine in Agitated Patients With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Staccato Loxapine in Agitated Patients With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721955).
- Staccato Prochlorperazine in Migraine (Out Patient): Complete Statistical AnalysisIndependent statistical analysis of Staccato Prochlorperazine in Migraine (Out Patient): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00422812).
- STAGEIndependent statistical analysis of A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab: Complete Statistical AnalysisIndependent statistical analysis of Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab: primary endpoint results, effect estimate with confidence…
- Stage I/II Nasal NK Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Stage I/II Nasal NK Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01321008).
- STAMPVAIndependent statistical analysis of Sharing and Talking About my Preferences: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03103828).
- STANDIndependent statistical analysis of Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- STANDIndependent statistical analysis of Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- STANDIndependent statistical analysis of A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Standard Colonoscopy Versus Colonoscopy With Endocuff Vision: Complete Statistical AnalysisIndependent statistical analysis of Standard Colonoscopy Versus Colonoscopy With Endocuff Vision: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03361917).
- Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004: Complete Statistical AnalysisIndependent statistical analysis of Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004: primary endpoint results, effect estimate with confidence…
- Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572): Complete Statistical AnalysisIndependent statistical analysis of Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Standard Versus Continuous Capecitabine in Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Standard Versus Continuous Capecitabine in Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418028).
- Standardization of Surgery on the Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Standardization of Surgery on the Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00679913).
- STARIndependent statistical analysis of Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- STARIndependent statistical analysis of Start Treatment and Recovery for Opioid Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04505540).
- STARIndependent statistical analysis of Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- STARIndependent statistical analysis of Tolperisone in Acute Muscle Spasm of the Back: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03802565).
- STAR Cape+BKM120 MBC With Brain Met: Complete Statistical AnalysisIndependent statistical analysis of STAR Cape+BKM120 MBC With Brain Met: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02000882).
- STAR-DIndependent statistical analysis of Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- STAR-OMIndependent statistical analysis of Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- STAR-TIndependent statistical analysis of Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04976530).